Cargando…
Targeting a proteolytic neoepitope on CUB domain containing protein 1 (CDCP1) for RAS-driven cancers
Extracellular proteolysis is frequently dysregulated in disease and can generate proteoforms with unique neoepitopes not found in healthy tissue. Here, we demonstrate that Abs that selectively recognize a proteolytic neoepitope on CUB domain containing protein 1 (CDCP1) could enable more effective a...
Autores principales: | Lim, Shion A., Zhou, Jie, Martinko, Alexander J., Wang, Yung-Hua, Filippova, Ekaterina V., Steri, Veronica, Wang, Donghui, Remesh, Soumya G., Liu, Jia, Hann, Byron, Kossiakoff, Anthony A., Evans, Michael J., Leung, Kevin K., Wells, James A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843743/ https://www.ncbi.nlm.nih.gov/pubmed/35166238 http://dx.doi.org/10.1172/JCI154604 |
Ejemplares similares
-
Cleaved CDCP1 marks the spot: a neoepitope for RAS-driven cancers
por: Donahue, Katelyn L., et al.
Publicado: (2022) -
CUB Domain Containing Protein 1 (CDCP1) modulates adhesion and motility in colon cancer cells
por: Orchard-Webb, David J, et al.
Publicado: (2014) -
Structural Requirements for Cub Domain Containing Protein 1 (CDCP1) and Src Dependent Cell Transformation
por: Kollmorgen, Gwendlyn, et al.
Publicado: (2012) -
A covalent inhibitor of K-Ras(G12C) induces MHC-I presentation of haptenated peptide neoepitopes targetable by immunotherapy
por: Zhang, Ziyang, et al.
Publicado: (2022) -
CDCP1 (CUB domain containing protein 1) is a potential urine-based biomarker in the diagnosis of low-grade urothelial carcinoma
por: Liu, Chien-Liang, et al.
Publicado: (2023)